Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ NTN1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA578289
Description
Positive Control: U87-MG conditioned medium, rat heart, rat spinal cord Predicted Reactivity: Mouse (100%), Chicken (100%), Bovine (100%) Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Netrin-1 is a protein target that plays a crucial role in various biological processes, particularly in the development and guidance of neuronal cells. It belongs to the netrin family of axon guidance molecules and is involved in mediating axon guidance, cell migration, and tissue morphogenesis during embryonic development. Netrin-1 functions by binding to specific receptors on the cell surface and providing directional cues for cellular movement and connectivity. Dysregulation of Netrin-1 has been implicated in various diseases, including cancer, neurological disorders, and cardiovascular conditions.
Specifications
NTN1 | |
Polyclonal | |
Unconjugated | |
NTN1 | |
AI561871; BC019633; Epididymis tissue protein Li 131P; HGNC:8029; netrin 1; netrin 1, mouse, homolog of; Netrin1; netrin-1; Ntn1; NTN1L | |
Rabbit | |
Protein A | |
RUO | |
114523, 18208, 9423 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot | |
0.53 mg/mL | |
PBS with 20% glycerol and 0.025% ProClin 300; pH 7 | |
O09118, O95631, Q924Z9 | |
NTN1 | |
Carrier-protein conjugated synthetic peptide encompassing a sequence within the center region of mouse Netrin 1. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction